Ezgi Atay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ezgi Atay has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Ruth E. Ley
Department of Microbiome Science, Max Planck Institute for Biology Tübingen, Tübingen, Germany
2 shared publications - Akshat Joshipura
Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich, Munich, Germany
1 shared publication - Alex S. Siebner
Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany
1 shared publication - Alexander V. Tyakht
Max Planck Institute for Biology
1 shared publication - Alfred Ke
Department of Pediatrics and Child Health, University of Manitoba, Manitoba, Canada
1 shared publication Alina Prokipchuk
Department of Microbiome Science, Max Planck Institute for Biology, Tübingen, Germany
1 shared publication
Latest Publications
- Open Access
- 10 October 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 10655
Extensive genomic diversity in Desulfovibrio reveals species-specific functional traits associated with disease
Desulfovibrio spp. are associated with inflammatory diseases and human health, yet limited representative genomes and isolates hinder our understanding of their role in disease. Here, we assembled a comprehensive database of 2658 Desulfovibrio genomes across 90 diseases and 32 countries, including 24 human isolates. Genomic analyses showed extensive species diversity and revealed disease-associated functional traits, including flagellin and adaptation-associated genes (i.e., ureases). Flagellin-mediated Toll-like receptor 5 activation was species-specific and D. desulfuricans flagellin downregulated TGF-beta signalling in murine small intestinal organoids, suggesting impaired immune tolerance. Additionally, we investigated genomic capacity for hydrogen sulfide (H 2 S) production, a main Desulfovibrio metabolite. While health- and disease-associated Desulfovibrio spp. mainly encoded dissimilatory sulfate reduction, tetrathionate metabolism-encoding bacteria were exclusively detected in inflammatory bowel diseases, including Proteus mirabilis and Morganella morganii . Overall, our study provides a comprehensive genomic Desulfovibrio resource and identifies new links associating strain variation, functional traits and H 2 S-production with inflammatory diseases.
- 10 October 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 10655
Open AccessExtensive genomic diversity in Desulfovibrio reveals species-specific functional traits associated with disease
Desulfovibrio spp. are associated with inflammatory diseases and human health, yet limited representative genomes and isolates hinder our understanding of their role in disease. Here, we assembled a comprehensive database of 2658 Desulfovibrio genomes across 90 diseases and 32 countries, including 24 human isolates. Genomic analyses showed extensive species diversity and revealed disease-associated functional traits, including flagellin and adaptation-associated genes (i.e., ureases). Flagellin-mediated Toll-like receptor 5 activation was species-specific and D. desulfuricans flagellin downregulated TGF-beta signalling in murine small intestinal organoids, suggesting impaired immune tolerance. Additionally, we investigated genomic capacity for hydrogen sulfide (H 2 S) production, a main Desulfovibrio metabolite. While health- and disease-associated Desulfovibrio spp. mainly encoded dissimilatory sulfate reduction, tetrathionate metabolism-encoding bacteria were exclusively detected in inflammatory bowel diseases, including Proteus mirabilis and Morganella morganii . Overall, our study provides a comprehensive genomic Desulfovibrio resource and identifies new links associating strain variation, functional traits and H 2 S-production with inflammatory diseases.
- 8 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 394 (6820)
The human gut microbiome primes fever after vaccination
Fever is a common adverse reaction to vaccination, contributing to vaccine hesitancy and reduced uptake. To understand variation in fever risk, we longitudinally profiled fecal microbiota, oral temperature, and serological markers in 171 healthy adults receiving Severe acute respiratory syndrome coronavirus 2 mRNA vaccines. Fever risk correlated with low-grade intestinal inflammation, increased abundance of flagellated Lachnospiraceae bacteria, and increased flagellin expression prevaccine. Microbiomes from fever-high donors triggered stronger inflammation in human intestinal organoids and drove flagellin-dependent vaccine reactions in gnotobiotic mice. Moreover, microbiome flagellin phenotypes and murine vaccine reactions were modifiable by diet. Consistent with this, human fever risk was associated with self-reported diet and metabolic markers. These findings identify the gut microbiome as a driver of vaccine-induced fever, suggesting that microbiome-targeting strategies could modulate immune tone and improve vaccine side effects.
- 8 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 394 (6820)
The human gut microbiome primes fever after vaccination
Fever is a common adverse reaction to vaccination, contributing to vaccine hesitancy and reduced uptake. To understand variation in fever risk, we longitudinally profiled fecal microbiota, oral temperature, and serological markers in 171 healthy adults receiving Severe acute respiratory syndrome coronavirus 2 mRNA vaccines. Fever risk correlated with low-grade intestinal inflammation, increased abundance of flagellated Lachnospiraceae bacteria, and increased flagellin expression prevaccine. Microbiomes from fever-high donors triggered stronger inflammation in human intestinal organoids and drove flagellin-dependent vaccine reactions in gnotobiotic mice. Moreover, microbiome flagellin phenotypes and murine vaccine reactions were modifiable by diet. Consistent with this, human fever risk was associated with self-reported diet and metabolic markers. These findings identify the gut microbiome as a driver of vaccine-induced fever, suggesting that microbiome-targeting strategies could modulate immune tone and improve vaccine side effects.